🔎 Trials Near Me

Gara Jalqabaatti › Kansa Endometiriyaalii › Alabama › Birmingham

Qorannoo klinikaalii Kansa Endometiriyaalii Birmingham, AL keessatti

Qorannoo 16 Kansa Endometiriyaalii f Birmingham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Alabama at Birmingham Cancer Center, Birmingham
Umuriin 18 fi ol · Dubartoota · Haaromfame 05-Onk-2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Namoota walitti qabaa jiraSadarkaa 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Birmingham
Umuriin 18 fi ol · Dubartoota · Haaromfame 02-Onk-2026 · NCT07286331

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Namoota walitti qabaa jiraSadarkaa 2
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06760819

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Umuriin 18 fi ol · Dubartoota · Haaromfame 28-Ful-2026 · NCT05112601

DESTINY-PANTUMOUR04

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Research Site, Birmingham
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Alabama_6th Ave, Birmingham
Umuriin 18 fi ol · Dubartoota · Haaromfame 25-Ful-2026 · NCT03564340

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Alabama at Birmingham, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Alabama Birmingham, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06293898

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Children's Hospital of Alabama, Birmingham
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Alabama at Birmingham, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT04657068

The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • University of Alabama at Birmingham, Birmingham
Umuriin 18 hanga 99 · Dubartoota · Haaromfame 29-Ado-2026 · NCT03538665

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Alabama at Birmingham, Birmingham
  • University of Alabama at Birmingham, IDS Pharmacy, Birmingham
  • University of Alabama at Birmingham, Birmingham
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT05208762

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Namoota walitti qabaa jiraSadarkaa 2
  • 004, Birmingham
Umuriin 18 fi ol · Dubartoota · Haaromfame 16-Ado-2026 · NCT06906341

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • O'Neal Comprehensive Cancer Center at UAB, Birmingham
Umuriin 18 fi ol · Dubartoota · Haaromfame 15-Elb-2026 · NCT05559879

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Birmingham
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Kansa Endometiriyaalii magaalota biroo keessatti

Qorannoo biroo Birmingham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.